Expertise in
2
conditions

Weiwei Ouyang

Guiyang, CN 
Expertise in
2
conditions
Guiyang, CN 

Overview

Weiwei Ouyang practices practicing medicine in Guiyang, China.

Ouyang is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Esophagitis.

They are actively involved in clinical research, co-authoring 51 peer reviewed articles and participating in 1 clinical trial.

Locations

Guiyang, 550001, China
Other Locations
China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Open-label, Single-arm, Phase Ib Study to Evaluate the Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Platinum-Resistant or Platinum-Refractory Relapsed Ovarian Cancer
A Multicenter, Open-label, Single-arm, Phase Ib Study to Evaluate the Safety and Efficacy of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Platinum-Resistant or Platinum-Refractory Relapsed Ovarian Cancer
Enrollment Status: Terminated
Publish Date: March 07, 2024
Intervention Type: Drug
Study Drug: Liposomal Mitoxantrone
Study Phase: Phase 1

51 Total Publications

Discovery of a highly selective FLT3-ITD inhibitor with potent antileukemic activity based on 4-(2-fluorophenoxy)pyridine scaffold.
Discovery of a highly selective FLT3-ITD inhibitor with potent antileukemic activity based on 4-(2-fluorophenoxy)pyridine scaffold.
Journal: European journal of medicinal chemistry
Published: July 28, 2026

Frequently Asked Questions about Weiwei Ouyang

Is Weiwei Ouyang a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?

MediFind is an objective health platform that identifies experts based on real-world data. Weiwei Ouyang is classified as an Advanced expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Weiwei Ouyang participate in research or clinical trials?

Yes. Weiwei Ouyang has published 51 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Weiwei Ouyang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ouyang's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile